** = Publications listed in SCI/SSCI/Pubmed
** Moser, O; Müller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Birnbaumer, P; Lenz, J; Mursic, I; Sternad, C; Hönger, L; Ziko, H; Pferschy, PN; Tripolt, N; Sourij, H
Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study).
Diabetes Technol Ther. 2023; 25(3):161-168
Doi: 10.1089/dia.2022.0422
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, C; Tripolt, NJ; Aziz, F; Aberer, F; Forstner, P; Obermayer, AM; Kojzar, H; Kleinhappl, B; Pferschy, PN; Mader, JK; Cvirn, G; Goswami, N; Wachsmuth, N; Eckstein, ML; Müller, A; Abbas, F; Lenz, J; Steinberger, M; Knoll, L; Krause, R; Stradner, M; Schlenke, P; Sareban, N; Prietl, B; Kaser, S; Moser, O; Steinmetz, I; Sourij, H, , COVAC-DM, study, group
Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2022; 24(5):849-858
Doi: 10.1111/dom.14643
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Moser, O; Aziz, F; Sourij, C; Ziko, H; Lenz, J; Abbas, F; Obermayer, AM; Kojzar, H; Pferschy, PN; Müller, A; Unteregger, C; Leitner, M; Banfic, T; Eckstein, ML; Wachsmuth, N; Kaser, S; Mader, JK; Tripolt, NJ; Sourij, H
Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study.
Diabetes Care. 2022; 45(2): e24-e26.
Doi: 10.2337/dc21-1563
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Muller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Birnbaumer, P; Eckstein, M; Honger, L; Lenz, J; Mursic, I; Sternad, C; Weber, B; Zanker, M; Ziko, H; Pferschy, P; Tripolt, N; Sourij, H
A comparison of Insulin Glargine U300 and Insulin Degludec around spontaneous exercise sessions in people with type 1 diabetes - the ULTRAFLEXI-1 study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):251-251.
[Oral Communication]
Web of Science
** Muller, A; Moser, O; Aberer, F; Abbas, F; Lenz, J; Sternad, C; Eckstein, M; Honger, L; Weber, B; Mursic, I; Zanker, M; Unteregger, C; Kojzar, H; Sourij, C; Pferschy, P; Tripolt, N; Sourij, H
IMPACT OF ENDURANCE TRAINING ON PHYSICAL PERFORMANCE IN PEOPLE WITH TYPE 1 DIABETES - AN ANALYSIS OF THE ULTRAFLEXI-1 STUDY
DIABETES TECHNOL THE. 2022; 24: A218-A218.
[Poster]
Web of Science
** Muller, A; Moser, O; Aziz, F; Aberer, F; Niedrist, T; Abbas, F; Lenz, J; Sternad, C; Jaruan, O; Glatz, U; Unteregger, C; Kojzar, H; Sourij, C; Pferschy, P; Tripolt, N; Sourij, H
Impact of endurance exercise on inflammatory markers in adults with type 1 diabetes - a secondary analysis of the -ULTRAFLEXI-1 study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):252-252.
[Poster]
Web of Science
** Sourij, H; Mueller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Eckstein, ML; Lenz, J; Sternad, C; Pferschy, PN; Tripolt, NJ; Ziko, H; Moser, O
Insulin glargine u300 versus insulin degludec around spontaneous exercise sessions in people with type 1 diabetes: the Ultraflexi-1 study
DIABETOLOGIA. 2022; 65(SUPPL 1):S220-S221.
[Oral Communication]
Web of Science
** Aberer, F; Moser, O; Sourij, C; Aziz, F; Ziko, H; Muller, A; Obermayer, AM; Kojzar, H; Pferschy, PN; Leitner, M; Lenz, J; Abbas, F; Banfic, T; Eckstein, ML; Wachsmuth, N; Tripolt, N; Kaser, S; Mader, JK; Sourij, H
The immediate Impact of the COVID-19 Vaccination on the Time in Range and the Bolus Insulin Dose in People with Type 1 Diabetes - Subgroup Analysis of a multicenter Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):222-222.
[Oral Communication]
Web of Science
** Muller, A; Moser, O; Abbas, F; Lenz, J; Sternad, C; Eckstein, ML; Honger, L; Weber, B; Mursic, I; Zanker, M; Unteregger, C; Kojzar, H; Sourij, C; Pferschy, P; Tripolt, N; Aberer, F; Sourij, H
Effect of several weeks of Endurance Training on physical Performance in People with Type 1 Diabetes - A secondary Analysis of a prospective clinical Trial
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):230-231.
[Oral Communication]
Web of Science
** Obermayer, A; Sourij, C; Aziz, F; von Lewinski, F; Kojzar, H; Pferschy, PN; Abbas, F; von Lewinski, D; Lenz, J; Tripolt, NJ; Aberer, F; Sourij, H
Assessment of Insulin Secretion using the C-Peptide/Glucose Ratio (CGR) in People with Type 2 Diabetes mellitus and Insulin Therapy - Data from the Graz Diabetes Register for Biomarker Research (GIRO)
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):227-227.
[Oral Communication]
Web of Science
** Tripolt, N; Sourij, C; Aberer, F; Kojzar, H; Obermayer, A; Pferschy, P; Aziz, F; Muller, A; Abbas, F; Lenz, J; Mader, J; Pesto, L; Banfic, T; Leitner, M; Steinberger, M; Knoll, L; Goswami, N; Moser, O; Eckstein, M; Wachsmuth, N; Cvirn, G; Stradner, M; Schlenke, P; Kaser, S; Steinmetz, I; Sourij, H
Immune Response to COVID-19 Vaccination for Patients with Diabetes mellitus - The Covac-DM Austria Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):228-228.
[Oral Communication]
Web of Science
** Obermayer, A; Sourij, C; Aziz, F; Kojzar, H; Pferschy, PN; Abbas, F; Lenz, J; Tripolt, N; Aberer, F; Sourij, H
Stages of CKD and cardiovascular Risk in Persons with Diabetes mellitus: Data from the Graz Diabetes Registry for Biomarker Research GIRO.
WIEN KLIN WOCHENSCHR. 2020; 132: S362-S363.
[Poster]
Web of Science